Collaboration combines Alloy’s antibody discovery and engineering platforms with Torpedo’s radiopharmaceutical development capabilities – including Terbium-161 – to advance next-generation oncology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback